A Trial of SHR-1139 in Healthy Volunteers

NCT07078695 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: SHR-1139 Injection
DRUG: SHR-1139 Injection
DRUG: SHR-1139 Injection

Sponsor

Atridia Pty Ltd.